City of Hope has long been a leader in myelodysplasia research, including promising new combinations of chemotherapy drugs, immunomodulators and stem cell transplant procedures. With our extensive program of clinical trials, City of Hope can provide our patients access to novel therapies, including many of those discussed above, that are not yet available elsewhere.

To learn more about our clinical trials program, click clinicaltrials.coh.org.